Atul Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Pat Growth 25pctExceptional ItemEbitda Margin ExpansionResults View source PDF Explain this filing

ATUL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹6694.00

prior close

₹6885.00

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.1%+0.4% vs market

Specialty Chemicals peers, median of 93sector-1.3%+0.7% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Smallcap 250 and 0.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

+0.1

15m

-0.8

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-1.1+0.4-1.3+0.7

Next day

+0.1+0.7-0.6+0.0+0.1

+2.8+0.8+2.0-0.2+3.0

+1.2+1.3-0.0-0.5+1.7

+2.0+0.8+1.1-0.1+2.0

+3.9+1.8+2.1+1.1+2.8

+6.2+3.9+2.3+2.2+4.0

15d

+2.8-0.7+3.5-1.4+4.2

+4.7+2.3+2.3+1.9+2.7

-1.1+7.2-8.3+3.0-4.1

-3.0+6.1-9.1+1.5-4.6

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 93Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Atul Limited reported strong full-year results for FY2026 (ended March 31, 2026). Standalone revenue grew 9.6% to ₹5,564 crore, while consolidated revenue rose 12.4% to ₹6,274 crore. Profit after tax surged 30.4% to ₹595 crore on standalone basis and 38.2% to ₹689 crore on consolidated basis. EPS improved to ₹202.11 (standalone) and ₹230.25 (consolidated). The Board proposed a dividend of ₹30 per share (300%) subject to shareholder approval at the July 31, 2026 AGM. The statutory auditors issued unmodified (clean) audit opinions on both standalone and consolidated results. The company also reappointed Mr. Samveg Lalbhai as Managing Director for 5 years from December 15, 2026.

Likely market impact

Strong profit growth exceeding 25% combined with a clean audit opinion and attractive dividend yield should be positive for shareholders. The company's chemical segments (Life Science Chemicals and Performance and Other Chemicals) both delivered solid revenue and profit growth.